TP53 and posterior cortical atrophy: Overexpression of p53 mutants leads to chemotherapy resistance and drug resistance (including resistance to cisplatin, temozolomide, doxorubicin, gemcitabine, tamoxifen and cetuximab) in primary PCa and metastatic PCa [120].